Allergy to heparin. Special problems set by pregnant women. 1992

M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
Laboratory of Immuno-Allergy, CHRU, Angers, France.

Oral anti-coagulants are always contra-indicated for pregnant women. Only anti-coagulants of the types of heparin or its derivatives may be used. However, some patients have an allergy to heparin. In this article the correct action to make both for diagnosis and prevention is studied. We present 2 observations of heparin-allergic pregnant women with, in the first case an attempted tolerization which failed and in the second case there was success in a second pregnancy with low-molecular weight heparin.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011249 Pregnancy Complications, Cardiovascular The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Cardiovascular Pregnancy Complications,Complications, Cardiovascular Pregnancy,Pregnancy, Cardiovascular Complications,Cardiovascular Pregnancy Complication,Complication, Cardiovascular Pregnancy,Pregnancies, Cardiovascular Complications,Pregnancy Complication, Cardiovascular
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
August 1977, Kango tenbo. The Japanese journal of nursing science,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
January 1982, Ginekologia polska,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
October 1964, Journal of the College of Radiologists of Australasia,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
November 2001, Archives des maladies du coeur et des vaisseaux,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
June 1993, Revista medica de Chile,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
January 1992, Nordisk medicin,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
April 1952, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
April 1952, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
November 1980, The Practitioner,
M Drouet, and F Le Pabic, and J Le Sellin, and J C Bonneau, and A Sabbah
February 1992, Contact dermatitis,
Copied contents to your clipboard!